Jnana Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in Jnana Therapeutics?

Jnana Therapeutics has 8 investors including AbbVie And Avalon Ventures.

Q: How much funding has Jnana Therapeutics raised to date?

Jnana Therapeutics has raised obfuscated.

Overview

Jnana Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Jnana Therapeutics

CB Rank

20986

Jnana Therapeutics develops innovative therapies using a chemoproteomics drug discovery platform.

Acquired by

Otsuka America

Founded

obfuscation

Private

Series C

Boston, Massachusetts, United States

51-100

www.jnanatx.com

Biotechnology

Health Care

Medical

Therapeutics

Funding Rounds

Series C

OBF

obfuscation

Series B

OBF

obfuscation

Series A

OBF

obfuscation

Key People

Joel Barrish: Co-founder, President & CSO
Past Role: Achillion Pharmaceuticals, Executive VP & CSO
John Throup: Co-Founder, Senior Vice President, Head of Development

Details

Legal Name

Jnana Therapeutics, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Amir Nashat, Joanne Kotz, Joel Barrish, John Throup

About the Company

Jnana Therapeutics is a biotechnology company focused on discovering and developing medicines that improve patient lives. Utilizing its RAPID platform, the firm accelerates the identification of therapeutic targets and the creation of small molecule therapies for various diseases. Jnana aims to enhance drug discovery efficiency through advanced

chemoproteomics techniques, addressing unmet medical needs.

Contact Email

info@jnanatx.com

Diversity Spotlight

Women Founded

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

JNT-517

An oral small molecule inhibitor targeting the phenylalanine transporter SLC6A19 to reduce blood phenylalanine levels in phenylketonuria (PKU) patients.

RAPID Platform

A proprietary chemoproteomic drug discovery platform that identifies small molecule modulators of solute carrier (SLC) transporters and other challenging targets.

Research & Development

Jnana Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series C - Jnana Therapeutics	7	obfuscated obfuscation	Bain Capital Life Sciences	Series C
obfuscated obfuscation	Series C - Jnana Therapeutics	7	obfuscated obfuscation	Bain Capital Life Sciences	Series C
obfuscated obfuscation	Series C - Jnana Therapeutics	7	obfuscated obfuscation	Bain Capital Life Sciences	Series C
obfuscated obfuscation	Series C - Jnana Therapeutics	7	obfuscated obfuscation	Bain Capital Life Sciences	Series C
obfuscated obfuscation	Series C - Jnana Therapeutics	7	obfuscated obfuscation	Bain Capital Life Sciences	Series C

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series C - Jnana Therapeutics	7	obfuscated obfuscation	Bain Capital Life Sciences	Series C
obfuscated obfuscation	Series C - Jnana Therapeutics	7	obfuscated obfuscation	Bain Capital Life Sciences	Series C
obfuscated obfuscation	Series C - Jnana Therapeutics	7	obfuscated obfuscation	Bain Capital Life Sciences	Series C
obfuscated obfuscation	Series C - Jnana Therapeutics	7	obfuscated obfuscation	Bain Capital Life Sciences	Series C
obfuscated obfuscation	Series C - Jnana Therapeutics	7	obfuscated obfuscation	Bain Capital Life Sciences	Series C

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
AbbVie	—	Series C - Jnana Therapeutics	—
AbbVie	—	Series C - Jnana Therapeutics	—
AbbVie	—	Series C - Jnana Therapeutics	—
AbbVie	—	Series C - Jnana Therapeutics	—
AbbVie	—	Series C - Jnana Therapeutics	—